Skip to main content
Anika Therapeutics, Inc. logo

Anika Therapeutics, Inc. — Investor Relations & Filings

Ticker · ANIK ISIN · US0352551081 LEI · 529900R9LS3Z0O6QH455 US Manufacturing
Filings indexed 1,017 across all filing types
Latest filing 2023-10-06 Major Shareholding Noti…
Country US United States of America
Listing US ANIK

About Anika Therapeutics, Inc.

https://anika.com/

Anika Therapeutics, Inc. is a global joint preservation company focused on developing, manufacturing, and marketing solutions for early intervention orthopedic care. The company provides a range of therapeutic products and regenerative solutions designed to treat degenerative orthopedic diseases, traumatic conditions, joint pain, and arthritis. Its portfolio, which utilizes technologies such as hyaluronic acid, aims to restore joint function and enable patients to maintain an active lifestyle. Key products include the Integrity™ Implant System, a regenerative scaffold for tendon augmentation. Anika partners with medical professionals to deliver treatments across the continuum of joint care.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2023
Major Shareholding Notification
2023-10-06 English
Director's Dealing 2023
Director's Dealing
2023-10-03 English
FORM 8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Anika Therapeutics, Inc. It includes an Item 7.01 Regulation FD Disclosure referencing an attached Investor Presentation (Exhibit 99.1) dated September 21, 2023. The text explicitly states that the Investor Presentation is furnished and not filed, and it is incorporated by reference. The document length is 4351 characters, which is relatively short and primarily serves to announce and furnish the Investor Presentation rather than containing the full presentation or detailed financial data itself. According to the MENU VS MEAL RULE, this is an announcement of a report (the Investor Presentation) rather than the report itself. Therefore, the appropriate classification is Investor Presentation (IP).
2023-09-21 English
ANIKA THERAPEUTICS, INC.
Major Shareholding Notification
2023-09-11 English
ANIKA THERAPEUTICS, INC.
Major Shareholding Notification
2023-08-17 English
Director's Dealing 2023
Director's Dealing
2023-08-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.